John E. Landers

15.6k total citations · 1 hit paper
53 papers, 2.6k citations indexed

About

John E. Landers is a scholar working on Neurology, Molecular Biology and Genetics. According to data from OpenAlex, John E. Landers has authored 53 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Neurology, 31 papers in Molecular Biology and 26 papers in Genetics. Recurrent topics in John E. Landers's work include Amyotrophic Lateral Sclerosis Research (32 papers), Neurogenetic and Muscular Disorders Research (26 papers) and RNA Research and Splicing (9 papers). John E. Landers is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (32 papers), Neurogenetic and Muscular Disorders Research (26 papers) and RNA Research and Splicing (9 papers). John E. Landers collaborates with scholars based in United States, Italy and United Kingdom. John E. Landers's co-authors include Donna L. George, Robert H. Brown, Linda J. Engle, Daryl A. Bosco, Peter C. Sapp, Pamela Keagle, Vincenzo Silani, Dale S. Haines, Nicola Ticozzi and Marka van Blitterswijk and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

John E. Landers

53 papers receiving 2.6k citations

Hit Papers

Amyotrophic lateral sclerosis: translating genetic discov... 2023 2026 2024 2025 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John E. Landers United States 33 1.5k 1.2k 711 409 313 53 2.6k
Christophe Roumier France 25 1.6k 1.1× 1.4k 1.2× 862 1.2× 342 0.8× 244 0.8× 72 4.1k
Ya-Fei Xu United States 22 1.9k 1.3× 2.2k 1.8× 1.0k 1.4× 230 0.6× 377 1.2× 30 3.6k
Edward V. Wancewicz United States 19 2.1k 1.4× 847 0.7× 595 0.8× 114 0.3× 103 0.3× 25 2.8k
Grazyna Adamus United States 34 1.1k 0.8× 1.1k 0.9× 198 0.3× 228 0.6× 189 0.6× 92 3.0k
Ewout J. N. Groen Netherlands 25 1.4k 0.9× 752 0.6× 1.1k 1.6× 68 0.2× 202 0.6× 57 2.3k
Shuying Sun United States 22 2.3k 1.5× 758 0.6× 543 0.8× 91 0.2× 132 0.4× 47 3.0k
Tatyana V. Taksir United States 17 1.0k 0.7× 334 0.3× 280 0.4× 336 0.8× 164 0.5× 24 1.9k
Kasey R. Hutt United States 12 2.4k 1.6× 834 0.7× 549 0.8× 127 0.3× 100 0.3× 17 3.0k
Paul N. Valdmanis United States 27 1.9k 1.2× 2.2k 1.8× 1.4k 1.9× 79 0.2× 201 0.6× 59 3.7k
Mingyao Ying United States 22 1.2k 0.8× 283 0.2× 303 0.4× 359 0.9× 128 0.4× 42 2.0k

Countries citing papers authored by John E. Landers

Since Specialization
Citations

This map shows the geographic impact of John E. Landers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Landers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Landers more than expected).

Fields of papers citing papers by John E. Landers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Landers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Landers. The network helps show where John E. Landers may publish in the future.

Co-authorship network of co-authors of John E. Landers

This figure shows the co-authorship network connecting the top 25 collaborators of John E. Landers. A scholar is included among the top collaborators of John E. Landers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John E. Landers. John E. Landers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mann, Jacob R., Francesco Alessandrini, Eric N. Anderson, et al.. (2023). Loss of function of the ALS-associated NEK1 kinase disrupts microtubule homeostasis and nuclear import. Science Advances. 9(33). eadi5548–eadi5548. 18 indexed citations
2.
Akçimen, Fulya, John E. Landers, Avindra Nath, et al.. (2023). Amyotrophic lateral sclerosis: translating genetic discoveries into therapies. Nature Reviews Genetics. 24(9). 642–658. 103 indexed citations breakdown →
3.
Simkin, Dina, Bernabé I. Bustos, Christina M. Ambrosi, et al.. (2022). Homozygous might be hemizygous: CRISPR/Cas9 editing in iPSCs results in detrimental on-target defects that escape standard quality controls. Stem Cell Reports. 17(4). 993–1008. 36 indexed citations
4.
Glass, Jonathan D., Ramita Dewan, Jinhui Ding, et al.. (2022). ATXN2 intermediate expansions in amyotrophic lateral sclerosis. Brain. 145(8). 2671–2676. 26 indexed citations
5.
Lin, Yen‐Chen, Nandini Ramesh, Eric N. Anderson, et al.. (2021). Interactions between ALS-linked FUS and nucleoporins are associated with defects in the nucleocytoplasmic transport pathway. Nature Neuroscience. 24(8). 1077–1088. 63 indexed citations
6.
Gumina, Valentina, Claudia Colombrita, Claudia Fallini, et al.. (2019). TDP-43 and NOVA-1 RNA-binding proteins as competitive splicing regulators of the schizophrenia-associated TNIK gene. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1862(9). 194413–194413. 16 indexed citations
7.
Danielson, Eric, Valentina Gumina, Sivakumar Boopathy, et al.. (2019). Modulation of actin polymerization affects nucleocytoplasmic transport in multiple forms of amyotrophic lateral sclerosis. Nature Communications. 10(1). 3827–3827. 54 indexed citations
8.
Pérez‐Carrión, María Dolores, Francesca Pischedda, Alice Biosa, et al.. (2018). The LRRK2 Variant E193K Prevents Mitochondrial Fission Upon MPP+ Treatment by Altering LRRK2 Binding to DRP1. Frontiers in Molecular Neuroscience. 11. 64–64. 32 indexed citations
9.
Sama, Reddy Ranjith K., Claudia Fallini, Rodolfo G. Gatto, et al.. (2017). ALS-linked FUS exerts a gain of toxic function involving aberrant p38 MAPK activation. Scientific Reports. 7(1). 115–115. 47 indexed citations
10.
Tran, Hélène, et al.. (2017). A Drosophila model of ALS reveals a partial loss of function of causative human PFN1 mutants. Human Molecular Genetics. 26(11). 2146–2155. 11 indexed citations
11.
Yang, Chunxing, Eric Danielson, Tao Qiao, et al.. (2016). Mutant PFN1 causes ALS phenotypes and progressive motor neuron degeneration in mice by a gain of toxicity. Proceedings of the National Academy of Sciences. 113(41). E6209–E6218. 76 indexed citations
12.
Smith, Bradley, Caroline Vance, Emma L. Scotter, et al.. (2014). Novel mutations support a role for Profilin 1 in the pathogenesis of ALS. Neurobiology of Aging. 36(3). 1602.e17–1602.e27. 81 indexed citations
13.
Calini, Daniela, Lucia Corrado, Roberto Del Bo, et al.. (2013). Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis. Neurobiology of Aging. 34(11). 2695.e11–2695.e12. 26 indexed citations
14.
Li, Shuping, Jinghao Sheng, Jamie K. Hu, et al.. (2012). Ribonuclease 4 protects neuron degeneration by promoting angiogenesis, neurogenesis, and neuronal survival under stress. Angiogenesis. 16(2). 387–404. 47 indexed citations
15.
Ticozzi, Nicola, Caroline Vance, Aurélie Leclerc, et al.. (2011). Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 156(3). 285–290. 136 indexed citations
16.
Ticozzi, Nicola, Ashley LeClerc, Marka van Blitterswijk, et al.. (2009). Mutational analysis of TARDBP in neurodegenerative diseases. Neurobiology of Aging. 32(11). 2096–2099. 52 indexed citations
17.
Broom, Wendy, Manuel Garber, Peter M. Andersen, et al.. (2009). DNA sequence analysis of the conserved region around the SOD1 gene locus in recessively inherited ALS. Neuroscience Letters. 463(1). 64–69. 6 indexed citations
18.
Charest, Alain, John Dowd, Justin P. Blumenstiel, et al.. (2002). Genome complexity reduction for SNP genotyping analysis. Proceedings of the National Academy of Sciences. 99(5). 2942–2947. 30 indexed citations
19.
Pykett, Mark, John E. Landers, & Donna L. George. (1997). Expression patterns of the p53 tumor suppressor gene and the mdm2 proto-oncogene in human meningiomas. Journal of Neuro-Oncology. 32(1). 39–44. 14 indexed citations
20.
Haines, Dale S., John E. Landers, Linda J. Engle, & Donna L. George. (1994). Physical and functional interaction between wild-type p53 and mdm2 proteins.. Molecular and Cellular Biology. 14(2). 1171–1178. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026